Cerebrofacial Arteriovenous Metameric Syndrome, also known as cams, is related to cerebrofacial arteriovenous metameric syndrome type 3 and cerebrofacial arteriovenous metameric syndrome type 1. The drugs Omacetaxine mepesuccinate and Daunorubicin have been mentioned in the context of this disorder. Affiliated tissues include occipital lobe and thalamus.